N-(4-Fluorophenyl)-4-methyl-2-(pyridin-2-yl)-1,3-thiazole-5-carboxamide

Catalog No. :
ACQWSY356
CAS No. :
400079-00-7
Molecular Formula :
C16H12FN3OS
Molecular Weight :
313.36

IUPAC Name:N-(4-fluorophenyl)-4-methyl-2-(pyridin-2-yl)thiazole-5-carboxamide

N-(4-Fluorophenyl)-4-methyl-2-(pyridin-2-yl)-1,3-thiazole-5-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Fluorophenyl)-4-methyl-2-(pyridin-2-yl)-1,3-thiazole-5-carboxamide
IUPAC NameN-(4-fluorophenyl)-4-methyl-2-(pyridin-2-yl)thiazole-5-carboxamide
MDL No.MFCD01936159
Molecular FormulaC16H12FN3OS
Molecular Weight313.36
SMILESO=C(C1=C(C)N=C(C2=NC=CC=C2)S1)NC3=CC=C(F)C=C3
InChI KeyQGLXALAOQMEHPC-UHFFFAOYSA-N
SynonymN-(4-fluorophenyl)-4-methyl-2-(pyridin-2-yl)-1,3-thiazole-5-carboxamide;5-Thiazolecarboxamide, N-(4-fluorophenyl)-4-methyl-2-(2-pyridinyl)-
CAS No.400079-00-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQWSY356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNTCH137 route compound structure diagram
    ACNTCH1372146-07-8 In Stock
  4. Then
  5. ACQWSY356 route product structure diagram
    ACQWSY356400079-00-7
Inquiry

2. ACQWSY356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWUCL331 route compound structure diagram
    ACWUCL331383146-88-1 In Stock
  2. Plus
  3. ACNTCH137 route compound structure diagram
    ACNTCH1372146-07-8 In Stock
  4. Then
  5. ACQWSY356 route product structure diagram
    ACQWSY356400079-00-7
Inquiry

Comments (0)